Colorectal cancer chemotherapeutic drug sensitivity prediction marker probe and application
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHONGQING UNIV CANCER HOSPITAL
- Publication Date
- 2022-07-22
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of gene detection, and in particular relates to a colorectal cancer chemotherapeutic drug sensitivity prediction marker probe and application. Background technique
[0002] Colorectal cancer (CRC) is one of the major malignant tumors threatening human health. The global cancer data in 2020 shows that the incidence of CRC accounts for 10.0% of all cancers in the world, and the mortality rate accounts for 9.4% of all cancer deaths; in China , the number of new cases of CRC is second only to lung cancer, becoming the second largest cancer. Epidemiological data show that in recent years, the morbidity and mortality of CRC in my country are on the rise. The main clinical manifestations of CRC are changes in bowel habits, abdominal pain, anemia and intestinal bleeding. However, most patients have no obvious symptoms in the early stage, which leads to the fact that CRC patients are mostly in the middle and late s...